- As China Slows Down, the Philippines Moves to Grab Foreign Investment
- Why Obamacare Subsidies Should Be Struck Down by the Supreme Court
- MannKind's Afrezza Earns Lackluster Review from Independent Drug Arbiter
- Shale Oil Bust Enters Phase Two, Led by Hercules and SandRidge
- Comcast Wants Congress to Gut the New Net Neutrality Rules
Doctor asks when profit becomes profiteering after Retrophin raises drug price by 20 times.
An inside look at how Intuitive Surgical botched the upgrade cycle for its high-price surgical robots.
A doctor rants against the naysyers and nitpickers slamming robotic surgery. It's here for good, so get used to it.